Phibro Animal Health reported $262.76M in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Align Technology ALGN:US USD 3.69B 95.54M
Ani Pharmaceuticals ANIP:US USD 336.68M 283K
Aurora Cannabis Inc ACB:CN CAD 556.45M 105.39M
Bristol Myers Squibb BMY:US USD 32.67B 71M
Canopy Growth Corp WEED:CN CAD 1.68B 9.07M
Corcept Therapeutics CORT:US USD 473.36M 31.04M
Depomed DEPO:US USD 134.92M 6.55M
Eli Lilly And LLY:US USD 10.07B 1.53B
Endo International Ordinary Shares ENDP:US USD -3925041000 726.97M
Henry Schein HSIC:US USD 3.61B 17M
Idexx Laboratories IDXX:US USD 476M 18.99M
Knight Therapeutics Inc GUD:CN CAD 854.52M 24.83M
Lannett LCI:US USD -277561000 26.5M
Nektar Therapeutics NKTR:US USD 412.22M 46.51M
Pacira Pharmaceuticals PCRX:US USD 770.12M 13.49M
Patterson Companies PDCO:US USD 1.03B 15.79M
Phibro Animal Health PAHC:US USD 262.76M 314K
Prestige Brands PBH:US USD 1.62B 35.1M
Supernus Pharmaceuticals SUPN:US USD 852.8M 11.36M
Teva Pharmaceutical Industries TEVA:US USD 8.77B 269M
Zoetis ZTS:US USD 4.66B 83M